Dtsch Med Wochenschr 2014; 139(S 03): S87-S88
DOI: 10.1055/s-0034-1369826
Zusammenfassung | Abstract
Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Wirksamkeit von Ceftarolin bei komplizierten Haut- und Weichgewebeinfektionen

Efficacy of ceftaroline in treating complicated skin and soft tissue infections
C. Eckmann
1   Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Klinikum Peine
› Author Affiliations
Further Information

Publication History

18 December 2013

16 January 2014

Publication Date:
27 November 2014 (online)

 
  • Literatur

  • 1 AMR Hospital Antibiotic Market Guide – Book 2. Diagnosis and Surgery Reports . Januar 2010–Juni 2010
  • 2 Corey GR, Wilcox M, Talbot GH et al. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 2010; 51: 641-650
  • 3 Corey GR, Wilcox MH, Talbot GH et al. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010; 65 (Suppl. 04) iv41-iv51
  • 4 Friedland HD, O'Neal T, Biek D et al. CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 2012; 56: 2231-2236
  • 5 Kumar A, Ellis P, Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136: 1237-1248
  • 6 Szumowski JD, Cohen DE, Kanaya F et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51: 423-428
  • 7 Wilcox MH, Corey GR, Talbot GH et al. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010; 65 (Suppl. 04) iv53-iv65